Compare Stocks: KZA, DDDD, and COV

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COV (COV)		$0.00	$65.97 ▼ $108.57	N/A	N/A	3.88 million shs	N/A

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COV (COV)	0.00%	0.00%	0.00%	0.00%	0.00%

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COV (COV)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COV (COV)	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COV (COV)	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COV (COV)	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COV (COV)	N/A	N/A	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
COV (COV)	N/A

Insider Ownership

Company	Insider Ownership
COV (COV)	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
COV (COV)	N/A	N/A	N/A	Not Optionable

KZA, DDDD, and COV Headlines

Source	Headline
	Longest case of COVID-19 was breeding ground for mutations, study shows msn.com - April 19 at 1:43 PM
	Dozens of COVID virus mutations arose in man with longest known case, research finds medicalxpress.com - April 19 at 1:43 PM
	Blood Biomarkers Reveal the Hidden World of Long COVID scitechdaily.com - April 19 at 8:43 AM
	Dozens of COVID Virus Mutations Arose in Man With Longest Known Case usnews.com - April 19 at 8:43 AM
	Closing Bell: CI Hlth Care Giants Cov Call ETF flat on Wednesday (FHI-B) theglobeandmail.com - April 19 at 1:08 AM
	Lungs of young adults more susceptible to SARS-CoV-2 virus: Research indiatvnews.com - April 19 at 1:08 AM
	COVID vaccines 'underutilized' in nursing homes, CDC analysis finds newsday.com - April 18 at 8:07 PM
	Covid Patient’s Infection Lasts Record 613 Days and Spawns New Mutations bloomberg.com - April 18 at 8:07 PM
	COVID Does Not Spur Asthma in Kids, Study Finds healthday.com - April 18 at 3:07 PM
	Lungs Of Young Adults More Susceptible To Covid-19 Causing SARS-CoV-2 Virus, Claims Study msn.com - April 18 at 10:03 AM
	New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses msn.com - April 17 at 11:15 PM
	COVID Not Linked to Increased Asthma Risk in Children: New Study techtimes.com - April 17 at 6:15 PM
	Arboviruses, mosquitoes and potential hosts tracked in real time in São Paulo city msn.com - April 17 at 6:15 PM
	7 out of 10 American voters think COVID-19 came from a lab deseret.com - April 17 at 6:15 PM
	COVID-19 caused 21% excess of respiratory infections last winter, analysis finds cidrap.umn.edu - April 17 at 6:15 PM
	What toilets can reveal about COVID, cancer and other health threats nature.com - April 17 at 8:13 AM
	7 out of 10 Americans think COVID-19 came from a lab msn.com - April 17 at 8:13 AM
	Study highlights how age affects nasal cell response to SARS-CoV-2 msn.com - April 17 at 1:48 AM
	Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses genengnews.com - April 16 at 8:47 PM
	Proximal Origins, Scientific Integrity, and “Shadow” Science Advice aei.org - April 16 at 3:47 PM
	Nasal Cells in Children Shield Against Severe COVID-19 msn.com - April 16 at 3:47 PM
	Rapid immune response of cells inside nose leads to milder cases of COVID-19 in kids msn.com - April 16 at 3:47 PM
	Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses news-medical.net - April 16 at 3:47 PM
	Long COVID Associated With Depressive Symptoms, Functional Impairment thecardiologyadvisor.com - April 16 at 10:36 AM

Company Descriptions

(COV)

NYSE:COV

Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Compare Stocks